Iovera
Total Payments
$4.2M
Transactions
15,393
Doctors
5,630
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.6M | 4,856 | 1,685 |
| 2023 | $1.6M | 6,470 | 2,705 |
| 2022 | $948,223 | 4,067 | 1,994 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.9M | 601 | 46.0% |
| Travel and Lodging | $1.1M | 3,970 | 26.7% |
| Food and Beverage | $435,173 | 10,579 | 10.4% |
| Honoraria | $349,436 | 100 | 8.4% |
| Unspecified | $286,418 | 108 | 6.9% |
| Long term medical supply or device loan | $36,498 | 26 | 0.9% |
| Space rental or facility fees (teaching hospital only) | $29,750 | 5 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,799 | 1 | 0.0% |
| Royalty or License | $1,600 | 1 | 0.0% |
| Grant | $300.00 | 1 | 0.0% |
| Education | $6.90 | 1 | 0.0% |
Payments by Type
General
$3.9M
15,285 transactions
Research
$286,418
108 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera®° system in Subjects with Upper Extremity Spasticity | Pacira Pharmaceuticals Incorporated | $278,645 | 0 |
| Preoperative (Pre-amputation) Cryoanalgesia to Improve Post-amputation Phantom Limb Pain, General physical and emotional disability, and Opioid Consumption: a randomized pilot trial | Pacira Pharmaceuticals Incorporated | $7,774 | 0 |
Top Doctors Receiving Payments for Iovera — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Surgery | Zephyrhills, FL | $3,525 | 1 |
| , M.D., M.P.H | Anesthesiology | Chicago, IL | $3,430 | 1 |
| , MD | Adult Reconstructive Orthopaedic Surgery | North Dartmouth, MA | $3,427 | 9 |
| , FNP | Family | Canon City, CO | $3,358 | 14 |
| , MD | Anesthesiology | Minneapolis, MN | $3,335 | 10 |
| , C.R.N.A | Nurse Anesthetist, Certified Registered | Wesley Chapel, FL | $2,959 | 8 |
| , MD | Orthopaedic Surgery | Germantown, TN | $2,948 | 2 |
| , M.D | Orthopaedic Surgery | Salem, VA | $2,802 | 5 |
| , PA | Physician Assistant | Waltham, MA | $2,791 | 4 |
| , MD | Neuromusculoskeletal Medicine, Sports Medicine | Los Angeles, CA | $2,750 | 3 |
| , M.D | Orthopaedic Surgery | Kennewick, WA | $2,626 | 7 |
| , M.D | Pediatric Rehabilitation Medicine | New York, NY | $2,619 | 10 |
| , M.D | Anesthesiology | Long Beach, CA | $2,519 | 5 |
| , MD | Pediatric Rehabilitation Medicine | Atlanta, GA | $2,496 | 8 |
| , M.D | Endocrinology, Diabetes & Metabolism | Potomac, MD | $2,405 | 6 |
| , MD | Orthopaedic Surgery | St. Louis, MO | $2,395 | 9 |
| , MD | Family Medicine | Rochester, MI | $2,352 | 19 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | New York, NY | $2,265 | 1 |
| , DNAP, CRNA | Registered Nurse | Asheville, NC | $2,238 | 6 |
| Bright Kim | Pain Medicine | Pittsburgh, PA | $2,225 | 9 |
| , PA | Physician Assistant | Sacramento, CA | $2,223 | 9 |
| , PA-C | Medical | Spokane, WA | $2,135 | 5 |
| , CRNA | Nurse Anesthetist, Certified Registered | Granbury, TX | $2,116 | 6 |
| , DNP, CRNA, NSPM-C | Interventional Pain Medicine | Polson, MT | $2,096 | 6 |
| , MD | Orthopaedic Surgery | Easton, MD | $2,033 | 13 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $4.2M
- Total Doctors 5,630
- Transactions 15,393
About Iovera
Iovera is a device associated with $4.2M in payments to 5,630 healthcare providers, recorded across 15,393 transactions in the CMS Open Payments database. The primary manufacturer is Pacira Pharmaceuticals Incorporated.
Payment data is available from 2022 to 2024. In 2024, $1.6M was paid across 4,856 transactions to 1,685 doctors.
The most common payment nature for Iovera is "Consulting Fee" ($1.9M, 46.0% of total).
Iovera is associated with 2 research studies, including "A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera®° system in Subjects with Upper Extremity Spasticity" ($278,645).